(Q71396691)
Statements
Short term treatment with soluble neuroantigen and anti-CD11a (LFA-1) protects rats against autoimmune encephalomyelitis: treatment abrogates autoimmune disease but not autoimmunity (English)
Willenborg DO
Staykova MA
1 September 1996